Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Immunogenicity of autologous and allogeneic human primary cholangiocyte organoid cellular therapies.
Immunogenicity of autologous and allogeneic human primary cholangiocyte organoid cellular therapies.
Journal: Cell reports. Medicine
Published: March 12, 2024
HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors.
Journal: European journal of immunology
Published: October 24, 2014
Showing 1-2 of 2
Last Updated: 09/26/2026